Kaplan Fox & Kilsheimer LLP Encourages GPGI, Inc. (NYSE: GPGI) Investors to Contact the Firm Before September 14, 2026

Kaplan Fox announced a class action lawsuit against GPGI (formerly CompoSecure) alleging the company overvalued Husky Technologies and misrepresented the benefits of the Husky acquisition to secure shareholder approval and PIPE funding, with losses tied to purchases from Nov. 3, 2025 to May 6, 2026. The acquisition was announced on Nov. 3, 2025 and completed on Jan. 12, 2026. A lead plaintiff must be appointed by Sept. 14, 2026, raising litigation risk and potential overhang for the stock.

Analysis

This is mostly a litigation-overhang event, not a true operating shock. The market mechanism is multiple compression: once investors believe the deal process may have been inflated or conflicted, they price in higher disclosure risk, legal expense, and a longer path to proving the transaction created durable value. For a company that used an acquisition narrative to justify capital allocation, the bigger second-order risk is not the complaint itself but the chance that future credibility discounts raise the cost of any follow-on financing or strategic transactions.

The immediate move can be exaggerated because attorney solicitations often front-run actual evidence. The tradable inflection is usually not the filing date but the next set of independent signals: reserve build, D&O coverage disputes, a goodwill/intangibles review, or a weak-quarter commentary that links legal distraction to execution. If the stock stabilizes while the company reiterates synergies and books no meaningful reserves, the headline premium can fade quickly over 1-3 months.

Contrarian view: the consensus may be overestimating cash cost and underestimating governance cost. Even if eventual damages are modest, the allegation profile can keep a persistent discount on acquisition-led growth stories for 6-18 months, especially if the board/sponsor relationship remains in focus. The main falsifier is a clean earnings print with no reserve action and a quick dismissal posture; that would turn this into a short-lived headline rather than a structural thesis.

Key Decisions for Investors

• CMPO: lean short on any 1-2 day relief rally; preferred expression is a near-dated put spread rather than outright short because headline-driven squeezes are common. Falsify if the company discloses no reserve build and reaffirms transaction synergies on the next call.
• CMPO: for holders, consider reducing exposure ahead of the next quarterly update; the best risk/reward for bears is when management is forced to quantify legal expense or address goodwill risk. Watch for impairment language as the real catalyst.
• Do not trade GPGI separately unless liquidity/borrow is clearly distinct; treat it as the same economic exposure as CMPO rather than a new alpha source.
• Set an alert for any 10-K/10-Q reserve, D&O insurance comment, or auditor language shift over the next 1-3 months; that is the first point where the event becomes materially investable.
• If the name is in a long-only book, pair-reduce by hedging with a payment/financials basket rather than sector shorts; this litigation is idiosyncratic, so broad beta hedges will be inefficient.